A retrospective study to evaluate efficacy of switching from intravitreal ranibizumab to aflibercept treatment in patients with wet age-related macular degeneration.
Phase of Trial: Phase IV
Latest Information Update: 13 Dec 2015
At a glance
- Drugs Aflibercept (Primary) ; Ranibizumab
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 13 Dec 2015 New trial record